Contribution of MRE11, RAD50, and NBS1 Genotypes to Bladder Cancer Susceptibility

CHENG-HSI LIAO; WEN-SHIN CHANG; HOU-YU SHIH; YUN-CHI WANG; CHE-LUN HSU; SHU-YU CHANG; CHAO-HSIANG CHANG; WEN-CHI CHEN; DA-TIAN BAU; CHIA-WEN TSAI

doi:10.21873/cgp.20523

Article Information

vol. 22 no. 4 575-591

DOI

https://doi.org/10.21873/cgp.20523

PMID

40571318

Published By

International Institute of Anticancer Research

Print ISSN

1109-6535

Online ISSN

1790-6245

History

Received April 9, 2025
Revision received April 18, 2025
Accepted April 22, 2025
Published online June 26, 2025.

Copyright © 2025 The Author(s). Published by the International Institute of Anticancer Research. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY-NC-ND) 4.0 international license (https://creativecommons.org/licenses/by-nc-nd/4.0).

Author Information

CHENG-HSI LIAO¹,²,*,
WEN-SHIN CHANG³,⁴,*,
HOU-YU SHIH³,⁴,*,
YUN-CHI WANG³,⁴,
CHE-LUN HSU⁴,
SHU-YU CHANG³,⁴,
CHAO-HSIANG CHANG⁵,
WEN-CHI CHEN⁵,
DA-TIAN BAU³,⁴,⁶ ⇑ and
CHIA-WEN TSAI³,⁴ ⇑

¹Taichung Armed Forces General Hospital, Taichung, Taiwan, R.O.C.;
²National Defense Medical Center, Taipei, Taiwan, R.O.C.;
³Terry Fox Cancer Research Laboratory, Department of Medical Research, China Medical University Hospital, Taichung, Taiwan, R.O.C.;
⁴Graduate Institute of Biomedical Sciences, China Medical University, Taichung, Taiwan, R.O.C.;
⁵School of Medicine, China Medical University, Taichung, Taiwan, R.O.C.;
⁶Department of Bioinformatics and Medical Engineering, Asia University, Taichung, Taiwan, R.O.C.

Da-Tian Bau and Chia-Wen Tsai, Terry Fox Cancer Research Laboratory, Department of Medical Research, China Medical University Hospital, 2 Yuh-Der Road, Taichung, 404 Taiwan, R.O.C. Tel: +886 422053366 ext. 5805, e-mail: 013280{at}tool.caaumed.org.tw (Bau); 017891{at}tool.caaumed.org.tw (Tsai)